Anavex Life Sciences Corp (AVXL)

[XenaLives]

It will be disclosed at a scientific conference as they have been saying for months.

do we interpret this statement that patients with these signature will benefit from A2-73 such that it will have positive impact on Alz?

No, better than that. I interpret it as enabling the company to hit consecutive bull's eyes in trials. This will lower cost and duration. I expect that there will be positive results (doesn't take much to beat BP's record) for those out of the bulls eye but homing in on that bulls eye will make trials less expensive and shorter in duration.

They will PR it offically - after accepted by FDA with substantial clinical justification.